Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P T Ninan

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
The American Journal of Psychiatry|April 1, 1984
CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patientsP T Ninan, D P van Kammen, M Scheinin, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 1, 1985
Neuropharmacological antagonism of the beta-carboline-induced "anxiety" response in rhesus monkeysJ N Crawley, P T Ninan, D Pickar, et al.
Archives of General Psychiatry|December 1, 1983
Reliability of norepinephrine and major monoamine metabolite measurements in CSF of schizophrenic patientsM Linnoila, P T Ninan, M Scheinin, et al.
Journal of Clinical Psychopharmacology|June 1, 2000
Placebo-controlled study of fluvoxamine in the treatment of patients with compulsive buyingP T Ninan, S L McElroy, C P Kane, et al.
The Journal of Clinical Psychiatry|July 13, 1999
Lithium augmentation fails to reduce symptoms in poorly responsive schizophrenic outpatientsS C Schulz, P A Thompson, M Jacobs, et al.
Science (New York, N.Y.)|May 27, 1983
Dopamine-beta-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophyD P van Kammen, L S Mann, D E Sternberg, et al.
Psychiatry Research|September 1, 1984
The Genain Quadruplets 25 years later: a diagnostic and biochemical followupL E DeLisi, A F Mirsky, M S Buchsbaum, et al.
Archives of General Psychiatry|May 1, 1997
Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatmentN R Schooler, S J Keith, J B Severe, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The American Journal of Psychiatry|April 1, 1984
CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patientsP T Ninan, D P van Kammen, M Scheinin, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 1, 1985
Neuropharmacological antagonism of the beta-carboline-induced "anxiety" response in rhesus monkeysJ N Crawley, P T Ninan, D Pickar, et al.
Archives of General Psychiatry|December 1, 1983
Reliability of norepinephrine and major monoamine metabolite measurements in CSF of schizophrenic patientsM Linnoila, P T Ninan, M Scheinin, et al.
Journal of Clinical Psychopharmacology|June 1, 2000
Placebo-controlled study of fluvoxamine in the treatment of patients with compulsive buyingP T Ninan, S L McElroy, C P Kane, et al.
The Journal of Clinical Psychiatry|July 13, 1999
Lithium augmentation fails to reduce symptoms in poorly responsive schizophrenic outpatientsS C Schulz, P A Thompson, M Jacobs, et al.
Science (New York, N.Y.)|May 27, 1983
Dopamine-beta-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophyD P van Kammen, L S Mann, D E Sternberg, et al.
Psychiatry Research|September 1, 1984
The Genain Quadruplets 25 years later: a diagnostic and biochemical followupL E DeLisi, A F Mirsky, M S Buchsbaum, et al.
Archives of General Psychiatry|May 1, 1997
Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatmentN R Schooler, S J Keith, J B Severe, et al.
Pageof 4